Want to see IMDX full AI Analyst Report?
Insight Molecular Diagnostics (IMDX) Ownership Overview
78.79% Insiders
2.25% Mutual Funds
3.21% Other Institutional Investors
2.34% ETFs
13.40% Public Companies and
Individual Investors
The ownership structure of Insight Molecular Diagnostics (IMDX) stock is a mix of institutional, retail, and individual investors. Approximately 7.80% of the company’s stock is owned by Institutional Investors, 78.79% is owned by Insiders, and 13.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 27, 2026 | xxxxxxxxxxxxx | $2029042 | |
Apr 20, 2026 | xxxxxxxxxxxxx | $652160 | |
Feb 12, 2026 | xxxxxxxxxxxxx | $2999999 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,369,925 | Insider | 77.53% | 110,105,475 | |
| 723,464 | Institution | 2.21% | 3,139,834 | |
| 529,234 | Institution | 1.62% | 2,296,876 | |
| 206,060 | Insider | 0.63% | 894,300 | |
| 196,462 | Institution | 0.60% | 852,645 | |
| 58,752 | Insider | 0.18% | 254,984 | |
| 55,807 | Insider | 0.17% | 242,202 | |
| 52,447 | Insider | 0.16% | 227,620 | |
| 43,826 | Institution | 0.13% | 190,205 | |
| 38,365 | Insider | 0.12% | 166,504 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 529,234 | Institution | 1.62% | 2,296,876 | |
| 196,462 | Institution | 0.60% | 852,645 | |
| 7,927 | Institution | 0.02% | 34,403 | |
| 3,200 | Institution | <0.01% | 13,888 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 475,405 | Institution | 1.45% | 2,210,633 | |
| 248,059 | Institution | 0.76% | 1,153,474 | |
| 43,826 | Institution | 0.13% | 190,205 |
FAQ
Who Owns Insight Molecular Diagnostics (IMDX)?
According to the latest TipRanks data, approximately 3.21% of the company's stock is held by institutional investors, 78.79% is held by insiders, and 13.40% is held by retail investors.
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.21% of Insight Molecular Diagnostics (IMDX) stock is held by institutional investors.
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.40% of Insight Molecular Diagnostics (IMDX) stock is held by retail investors.
Who owns the most shares of Insight Molecular Diagnostics (IMDX)?
Broadwood Partners Lp owns the most shares of Insight Molecular Diagnostics (IMDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.